XANO Industri (XANO) Q3 2025 earnings summary

Executive summary

• Operating profit for Q3 2025 significantly exceeded the prior year, driven by margin improvements and a property sale, with continued growth in MedTech, pharma, and defense offsetting lower project volumes in other sectors.

• Profitability improvements were prioritized over growth amid weak traditional markets, with a focus on resource efficiency and new business niches.

Financial highlights

• Net sales for Q1–Q3 2025 were SEK 2,558m (2,458), up 4% year-over-year; Q3 sales were SEK 785m (737), up nearly 7%.

• Operating profit for Q1–Q3 was SEK 270m (105), with a margin of 10.6% (4.3%); Q3 operating profit was SEK 110m (13), margin 14.0% (1.7%).

• Adjusted operating profit for Q1–Q3 was SEK 229m (110), margin 9.0% (4.5%).

• Profit before tax for Q1–Q3 was SEK 212m (51); adjusted profit before tax SEK 171m (56).

• Earnings per share for Q1–Q3 were SEK 2.83 (0.66); Q3 EPS was SEK 1.26 (-0.11).

• Cash flow from operations for Q1–Q3 was SEK 309m (139); Q3 cash flow was SEK 161m (129).

Outlook and guidance

• No major market changes expected in the near term; global uncertainty continues to dampen business climate in several sectors.

• Companies are gaining market share and entering new niches, with future growth dependent on new project ramp-ups.

• Strong financial position enables continued investments and increased acquisition activity.